ADEPTHERA, LLC
Palo Alto, CA · Biotech · Defunct
Adrenomedullin peptide analog gels that self-assemble in situ for sustained wound healing in diabetic ulcers
- Grants
- $2.7M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 4 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A hormonal therapy for preeclampsia | $223,676 | |
| Federal grant | Department of Health and Human Services · Phase I · A hormonal therapy for bronchopulmonary dysplasia | $299,299 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Novel Nanomedicine for Treatment resistant Hypertension RHTN | $296,941 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Novel Nanomedicine for Treatment-resistant Hypertension (RHTN) | $296,941 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Therapeutics for Endothelial Dysfunction | $290,425 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a novel anti-migraine therapeutics | $248,910 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a treatment-resistant hypertension (RHTN) depot therapeutics | $338,152 | |
| Federal grant | Department of Health and Human Services · Phase I · A therapy for improving diabetic ulcer healing | $335,342 | |
| Federal grant | Department of Health and Human Services · Phase I · Regenerative peptide therapy to accelerate pressure ulcer healing | $367,577 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2930 | Nautilus Biotechnology | — | — |
| 2931 | Annias Immunotherapeutics, Inc. | — | — |
| 2932 | INDUSTRIAL SONOMECHANICS, LLC | — | — |
| 2933 | ADEPTHERA, LLC | — | — |
| 2934 | SELECTA BIOSCIENCES, INC. | — | — |
| 2935 | QUANTUMBIO INC | — | — |
| 2936 | CBS THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptide Analogsapplication
- Peptide Analogsgranted
- Dosing And Use Of Long-acting Clr/ramp Agonistsgranted
- Superagonist Polypeptide Analogs Of Adrenomedullin And Intermedin Peptide Hormonesapplication
- Peptide Analogsgranted
- Superagonist Polypeptide Analogs Of Adrenomedullin And Intermedin Peptide Hormonesgranted
- Gel-forming Polypeptidesapplication
- Peptide Analogsapplication
- Gel-forming Polypeptidesapplication
- Peptide Analogsapplication
- Dosing And Use Of Long-acting Clr/ramp Agonistsapplication
- Peptide Analogsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.